The Pharma Data

DECEMBER 10, 2020

The ADSs have been approved for listing on the Nasdaq Global Select Market and are expected to begin trading on December 11, 2020 under the ticker symbol “NBTX.” The Company’s ordinary shares are listed on the regulated market of Euronext Paris under the ticker symbol “NANO.”.

Marketing 52

Marketing Regulations Treatment Clinical Trials 52

New Drug Approvals

JUNE 11, 2025

2] Gepirone was synthesized by Bristol-Myers Squibb in 1986 and was developed and marketed by Fabre-Kramer Pharmaceuticals. [4] 2003 Jun;25(6):1618-33. 1] It is taken orally. [1] 1] Side effects of gepirone include dizziness , nausea , insomnia , abdominal pain , and dyspepsia (indigestion). [1] 9 (3): 821–829. doi : 10.1111/j.1743-6109.2011.02624.x.

FDA 62

FDA FDA Approval Treatment Clinical Trials 62

Drug Target Review

AUGUST 26, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Science 59

Science Research Marketing 59

FDA Law Blog: Biosimilars

SEPTEMBER 19, 2023

The closest FDA has come is in a 2003 preamble noting that patents that claim finished dosage forms—which can include “metered aerosols, capsules, metered sprays, gels, and pre-filled drug delivery systems”—should be listed in the Orange Book, suggesting that a patent that claims both the drug substance and the delivery device should be listed.

FDA 105

FDA Drugs Biosimilars FDA Approval 105

Drug Target Review

JUNE 20, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Science 64

Science Research Marketing Drugs 64

Drug Target Review

MAY 15, 2024

The latter group (ie, most of us) are waiting for wet lab validation, market demonstration (FDA approvals), and a few other things (which we often cannot define). Crossing the Chasm: Marketing and Selling high-tech Products to Mainstream Customers. Drug Discovery & Development. 20 biotech startups attracted almost $3B in Q1 2024.

FDA Approval 59

FDA Approval FDA Science Marketing 59

Drug Target Review

JUNE 24, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Science 69

Science Engineering Research Drugs 69

Drug Target Review

AUGUST 14, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Engineering 59

Engineering Science Drugs Research 59

Drug Target Review

JULY 24, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Clinical Trials 59

Clinical Trials Science Research Trials 59

The Pharma Data

SEPTEMBER 8, 2021

For example, in 2001 with anthrax and 2003 with SARS-CoV1, TIB Molbiol demonstrated their ability to develop PCR assays for the detection of new pathogens within days. TIB Molbiol is a biotech company that has supplied the global market with reagents for research and medical diagnostics for over 30 years. About TIB Molbiol.

Virus 52

Virus Assay Development Disease Research 52

The Pharma Data

OCTOBER 21, 2020

Founded in 2003, Athenex, Inc. To participate in the call, dial 877-407-0784 (domestic) or 201-689-8560 (international) fifteen minutes before the conference call begins and reference the conference passcode 13711719. About Athenex, Inc.

Engineering 40

Engineering Therapies Treatment International 40

The Pharma Data

MARCH 8, 2021

Ridgeback markets EbangaTM for the treatment of Ebola and has a late-stage development pipeline which includes molnupiravir for the treatment of COVID-19. Headquartered in Miami, Florida, Ridgeback Biotherapeutics LP is a biotechnology company focused on emerging infectious diseases.

Trials 69

Trials Virus RNA Research Laboratories 69

Perficient: Drug Development

OCTOBER 3, 2023

Bill Davis Senior Vice President, Marketing & Alliances As senior vice president of marketing and alliances, Bill Davis is responsible for Perficient’s global marketing and communications functions. Bill has led marketing at Perficient since 2003, in a period of intense growth.

Engineering 52

Engineering Marketing Production 52

Common Sense for Drug Policy Blog

JANUARY 5, 2024

Part of this 'performance' has to do with adapting to the different temporal demands of the labor market—in other words, the management of sleep and wakefulness. In the current 'gig economy' — dominated by those jobs in which people are paid by the task, rather than receiving a fixed salary — work never stops. As Crary ( 2013 , p.

Pharmacy 52

Pharmacy Regulations Production Marketing 52

Drug Target Review

SEPTEMBER 24, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Government 59

Government Science Research Drugs 59

Drug Target Review

MAY 24, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

RNA 59

RNA Bioinformatics DNA Science 59

The Pharma Data

JANUARY 25, 2021

The company was founded in 2003 based on innovative research from Uppsala University , Sweden. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market and outlicensing potential.

Pharmaceutical Companies 40

Pharmaceutical Companies Disease Treatment Pharmaceuticals 40

The Pharma Data

MARCH 13, 2021

Fei-Fei Li (44), a leading expert in artificial intelligence and Professor in the Computer Science Department at Stanford University in California, and Alberto Weisser (65), a renowned agricultural expert with decades of capital market experience in the United States. Li and Weisser are intended to succeed Johanna W.

International 52

International Engineering Science Marketing 52

The Pharma Data

JANUARY 18, 2021

The company’s common shares are listed on the Euronext Growth Paris market (Ticker: ALBPS -ISIN: FR0012816825). The company is based in Paris, France, and Cambridge, Massachusetts. Disclaimer This press release contains forward-looking statements. Forward-looking statements include all statements that are not historical facts.

Regulations 40

Regulations Clinical Trials Disease Production 40

Drug Target Review

SEPTEMBER 13, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Science 59

Science Research Marketing Drugs 59

The Pharma Data

NOVEMBER 11, 2020

departing in 2003 to become the chief scientific officer for Tapestry Pharmaceuticals and ChromaDex Inc. He attributes his success to good fortune and hard work, and hopes to see some of his patented compounds gain approval and reach market readiness in the coming years. In 2009, he established Ironstone Separations Inc.,

Science 52

Science Organic Chemistry Pharmaceuticals Pharmacy 52

The Pharma Data

JANUARY 26, 2021

The company was founded in 2003 based on innovative research from Uppsala University , Sweden. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market and out-licensing potential.

Disease 40

Disease Pharmaceutical Companies Treatment Licensing 40

Drug Channels

FEBRUARY 23, 2021

For background, see Express Scripts + Prime Therapeutics: Our Four Takeaways From This Market Changing Deal. Dave Marley has just sold Marley Drug, the independent pharmacy he founded in 2003, to Medicure Pharma. Re: UnitedHealthcare Coverage Policies , American Hospital Association. The battle for specialty drug margin rages on.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Independent Pharmacies 52

Drug Target Review

OCTOBER 14, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Science 52

Science Pharmaceutical Companies Drug Development Pharmaceuticals 52

The Premier Consulting Blog

JANUARY 17, 2023

The Pediatric Research Equity Act (PREA) was signed into law in 2003 to increase pediatric use information in product labeling and close knowledge gaps regarding the safety, efficacy, and appropriate dosing of drugs to treat children.

Production 52

Production Clinical Trials FDA Disease 52

Drug Target Review

OCTOBER 24, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Cell Based Assays 52

Cell Based Assays Science Disease Doctors 52

The Pharma Data

OCTOBER 1, 2021

Currently, the quality dose for all marketed GBCAs, including gadobutrol and gadoterate, is 0.1 Approved indications include CE MRI of the CNS, CE-MRA (2003), CE MRI of the liver and kidneys (2007), and CE MRI of all body regions (whole body, 2012) within the EU and other countries. mmol/kg weight. “At

Clinical Trials 52

Clinical Trials Hospitals Disease Production 52

The Pharma Data

DECEMBER 15, 2020

Klisyri will be manufactured by Athenex, highlighting the vertically integrated capabilities of the company ranging from a preclinical lead to a developed product for market launch. Mr. Peter Guenter, CEO of Almirall, stated, “We are delighted to partner with Athenex to market Klisyri in the U.S. Founded in 2003, Athenex, Inc.

FDA Approval 52

FDA Approval Treatment FDA Therapies 52

FDA Law Blog: Biosimilars

FEBRUARY 27, 2024

. § 156 and interpretive case law, if an applicant for patent term extension has multiple NDA approvals of a product, PTE applicant can only rely on ‘a’ (single) regulatory review period for a first permitted commercial marketing or use of a product to establish the requirements for patent term extension. 2003) , and Biogen lnt’l v.

FDA Approval 59

FDA Approval FDA Production Therapies 59

The Premier Consulting Blog

AUGUST 21, 2024

The major markets follow ICH guidelines, which affords harmonization of a significant portion of the chemistry, manufacturing, and controls (CMC) content. There remains, however, key differences in regulatory requirements from both a content and format perspective.

Clinical Development 52

Clinical Development Pharmaceuticals Clinical Trials Trials 52

The Pharma Data

NOVEMBER 4, 2020

From 2003 to 2014, Mr. Thoresen was the managing director of Nycomed Pharma AS acquired by Takeda Pharmaceutical Company Limited in 2011 as part of an acquisition transaction with a total value of approximately USD $14B. XPhyto Therapeutics Corp. XPhyto Therapeutics Corp.: Hugh Rogers, CEO and Director.

Pharmaceutical Companies 40

Pharmaceutical Companies International Pharmaceuticals Production 40

Perficient: Drug Development

JANUARY 25, 2024

This is a disappointing reversal for payers, as the 2010 results showed a nine-point gain compared to the 2003 figure. consumers shows health insurance companies declined 11 percentage points among respondents rating their experience “Excellent” or “Good.” But the 2023 results now put payers two points below where they stood 20 years prior.

Nurses 52

Nurses Health Insurance Companies Pharmaceutical Companies Hospitals 52

Drug Target Review

FEBRUARY 14, 2025

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd in Cambridge.

Drugs 52

Drugs Research Immune Response Science 52

The Pharma Data

NOVEMBER 9, 2020

About NANOBIOTIX: www.nanobiotix.com Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

Immune Response 40

Immune Response Therapies Clinical Trials Treatment 40

BMG Labtech

OCTOBER 4, 2023

Next-generation sequencing technologies The number of options for researchers looking for sequencing instruments has increased significantly in recent years and represents a rapidly changing and increasingly competitive market. The MiSeq was launched in 2011 and is the oldest next-generation sequencing sequencer on the market.

DNA 52

DNA RNA Bioinformatics Research 52

Agency IQ

SEPTEMBER 15, 2023

Until recently, the FDA relied on a monograph process through which firms could bring OTC drugs to market without FDA approval so long as it adhered to pre-set terms under the monograph. CHPA predicted that the removal of oral phenylephrine from the market would lead to significant burden to both consumers and the healthcare system.

Science 40

Science FDA Clinical Trials Clinical Pharmacology 40

Agency IQ

JUNE 7, 2024

The regulations increase focus on post-market requirements and expect continuous and instantaneous updates to all reports and documents when either the product or the benefit-risk ratio changes. Key Documents and Dates Single Market Compliance Space (NANDO) database Notified Body applications for designation

Regulations 40

Regulations Compliance Packaging Production 40